These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
226 related items for PubMed ID: 6695682
1. Electrophysiologic and hemodynamic effects of propafenone, a new antiarrhythmic agent, on the anesthetized, closed-chest dog: comparative study with lidocaine. Karagueuzian HS, Katoh T, McCullen A, Mandel WJ, Peter T. Am Heart J; 1984 Mar; 107(3):418-24. PubMed ID: 6695682 [Abstract] [Full Text] [Related]
2. Comparative electrophysiologic and hemodynamic effects of several amide local anesthetic drugs in anesthetized dogs. Bruelle P, LeFrant JY, de La Coussaye JE, Peray PA, Desch G, Sassine A, Eledjam JJ. Anesth Analg; 1996 Mar; 82(3):648-56. PubMed ID: 8623976 [Abstract] [Full Text] [Related]
3. Influence of duration of rapid ventricular pacing on ventricular refractoriness in the presence of propafenone and lidocaine. Stark U, Stark G, Kasper K, Schwarzl I, Decrinis M, Pilger E, Tritthart HA. Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):43-50. PubMed ID: 9121970 [Abstract] [Full Text] [Related]
4. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia. Chilson DA, Heger JJ, Zipes DP, Browne KF, Prystowsky EN. J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099 [Abstract] [Full Text] [Related]
5. Electrophysiologic and hemodynamic effects of intravenous propafenone in patients with recurrent ventricular tachycardia. Shen EN, Sung RJ, Morady F, Schwartz AB, Scheinman MM, DiCarlo L, Shapiro W. J Am Coll Cardiol; 1984 May; 3(5):1291-7. PubMed ID: 6707382 [Abstract] [Full Text] [Related]
6. [The comparative hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction (comparison of propafenone and lidocaine) (author's transl)]. Beck OA, Vogt J, Hochrein H. Z Kardiol; 1978 Jan; 67(1):41-5. PubMed ID: 629072 [Abstract] [Full Text] [Related]
7. Hemodynamic and electrophysiologic effects of combined infusion of lidocaine and propafenone in humans. Feld GK, Nademanee K, Singh BN, Kirsten E. J Clin Pharmacol; 1987 Jan; 27(1):52-9. PubMed ID: 3680555 [Abstract] [Full Text] [Related]
8. Epicardial, endocardial and transmural mapping in assessing electrophysiological effects of 14-C lidocaine and 14-C propafenone on activation times in experimental chronic myocardial infarction. Correlations with myocardial drugs concentrations. Naccarella FF, Agarwal JB, Weintraub WS, Bracchetti D, Helfant RH. G Ital Cardiol; 1984 Oct; 14(10):825-9. PubMed ID: 6519392 [Abstract] [Full Text] [Related]
9. Assessment of the antiarrhythmic profile of the new class I agent diprafenone. Gülker H, Thale J, Olbing B, Heuer H, Frenking B, Bender F. Arzneimittelforschung; 1985 Oct; 35(9):1387-93. PubMed ID: 4084340 [Abstract] [Full Text] [Related]
10. The electrophysiologic effects of propafenone hydrochloride in the neonatal canine. Villafane J, Gelband H, Xu H, McCormack J, Stolfi A, Pickoff AS. Pediatr Res; 1987 Jul; 22(1):50-4. PubMed ID: 3627871 [Abstract] [Full Text] [Related]
11. Pharmacologic conversion and suppression of experimental canine atrial flutter: differing effects of d-sotalol, quinidine, and lidocaine and significance of changes in refractoriness and conduction. Feld GK, Venkatesh N, Singh BN. Circulation; 1986 Jul; 74(1):197-204. PubMed ID: 3708774 [Abstract] [Full Text] [Related]
12. Ethmozine: electrophysiology, hemodynamics, and antiarrhythmic efficacy in patients with life-threatening ventricular arrhythmias. Dorian P, Echt DS, Mead RH, Lee JT, Lebsack CS, Winkle RA. Am Heart J; 1986 Aug; 112(2):327-33. PubMed ID: 3526852 [Abstract] [Full Text] [Related]
14. [Electrophysiologic effects of propafenone in patients with sinus node dysfunction]. Alboni P, Filippi L, Pirani R, Preziosi S, Paparella N. G Ital Cardiol; 1984 Apr; 14(4):297-303. PubMed ID: 6735023 [Abstract] [Full Text] [Related]
15. Electrophysiologic effects of propafenone on canine ischemic cardiac cells. Zeiler RH, Gough WB, El-Sherif N. Am J Cardiol; 1984 Aug 01; 54(3):424-9. PubMed ID: 6465028 [Abstract] [Full Text] [Related]
16. Cardiac electrophysiological effects of propafenone and its 5-hydroxylated metabolite in the conscious dog. Boucher M, Chassaing C, Hamel JD, Poirier JM. Eur J Pharmacol; 1996 Nov 14; 315(2):171-7. PubMed ID: 8960881 [Abstract] [Full Text] [Related]
17. [Electrophysiologic characterization of propafenone in man]. Masini G, Dianda R, Masini M. G Ital Cardiol; 1984 Apr 14; 14(4):293-6. PubMed ID: 6735022 [Abstract] [Full Text] [Related]
18. Hemodynamic effects of antiarrhythmic drugs in acute myocardial infarction. Lotto A, Finzi A, Massari FM, Pagnoni F, Valentini R, Ambrosini F, Lo Masto M. G Ital Cardiol; 1984 Oct 14; 14(10):762-7. PubMed ID: 6519385 [Abstract] [Full Text] [Related]
19. Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone. von Philipsborn G, Gries J, Hofmann HP, Kreiskott H, Kretzschmar R, Müller CD, Raschack M, Teschendorf HJ. Arzneimittelforschung; 1984 Oct 14; 34(11):1489-97. PubMed ID: 6543124 [Abstract] [Full Text] [Related]
20. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation. Doherty JU, Waxman HL, Kienzle MG, Cassidy DM, Marchlinski FE, Buxton AE, Josephson ME. J Am Coll Cardiol; 1984 Aug 14; 4(2):378-81. PubMed ID: 6736479 [Abstract] [Full Text] [Related] Page: [Next] [New Search]